预防恶性肿瘤患者静脉血栓栓塞症的临床分析

王莉, 刘义, 高芸菲, 孔曼, 孔斌, 杨建东, 黄希芬, 裴文仲

王莉, 刘义, 高芸菲, 孔曼, 孔斌, 杨建东, 黄希芬, 裴文仲. 预防恶性肿瘤患者静脉血栓栓塞症的临床分析[J]. 实用临床医药杂志, 2013, (7): 118-120. DOI: 10.7619/jcmp.201307043
引用本文: 王莉, 刘义, 高芸菲, 孔曼, 孔斌, 杨建东, 黄希芬, 裴文仲. 预防恶性肿瘤患者静脉血栓栓塞症的临床分析[J]. 实用临床医药杂志, 2013, (7): 118-120. DOI: 10.7619/jcmp.201307043
Clinical analysis of venous thromboembolism prevention for patients with malignant tumor[J]. Journal of Clinical Medicine in Practice, 2013, (7): 118-120. DOI: 10.7619/jcmp.201307043
Citation: Clinical analysis of venous thromboembolism prevention for patients with malignant tumor[J]. Journal of Clinical Medicine in Practice, 2013, (7): 118-120. DOI: 10.7619/jcmp.201307043

预防恶性肿瘤患者静脉血栓栓塞症的临床分析

基金项目: 中国高校医学期刊临床专项资金
详细信息
  • 中图分类号: R730.6

Clinical analysis of venous thromboembolism prevention for patients with malignant tumor

  • 摘要: 目的 探讨预防恶性肿瘤患者静脉血栓栓塞症的临床方法.方法 将80例恶性肿瘤住院患者随机分为干预组60例和对照组20例.干预组根据血栓弹力图及凝血检查结果进行相应干预;对照组不予干预.干预组再根据不同高凝因素分为深静脉血栓(DVT)形成组(A组)、红细胞聚集组(B组)、无血栓及红细胞聚集组(C组),每组20例.观察各组患者下肢DVT形成、肺血栓栓塞症(PTE)以及出血事件发生情况.结果 住院期间,干预组DVT发生率、致死性PTE发生率均显著低于对照组.各组住院期间以及出院随访期间出血事件比较,差异均无统计学意义.结论 对于恶性肿瘤患者,根据血栓弹力图及凝血提示了解血栓形成早期凝血改变,并实施积极干预,可有效降低DVT及PTE发生率.根据不同致高凝状态,寻找不同因素,采取个体化治疗,可确保治疗的有效性及安全性.
  • Khorana A A, Francis C W, Culakova E. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy [J]. Journal of Thrombosis and Haemostasis, 2007(3):632.
    曹健鹏, 李俊海. 恶性肿瘤并发DVT的临床观察 [J]. 中国肿瘤临床, 2010, (24):1486.doi: 10.3969/j.issn.1000-8179.2010.24.031.
    Prandoin P, Falanga A, Piccioli A. Cancer and venous thromboembolism [J]. Lancol, 2005(6):401.
    Lee A Y, Levine M N. Venous thromboembolism and cancer:Risks and outcomes [J]. Circulation, 2003, (suppl 1):117.
    Bergrem A, Dahm A E, Jacobsen A F. Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism:a population-based case-control study [J]. Thrombosis and Haemostasis, 2012(6):1165.
    Thodiyil P A, Kakkar A K. Variation in relative risk of venous thromboembolism in different cancers [J]. Thrombosis and Haemostasis, 2002(6):1076.
    Khorana A A, Fine R L. Pancreatic cancer and thromboembolic disease [J]. Lancet Oncology, 2004, (11):655.
    陈文慧, 王辰. 恶性肿瘤与血栓性疾病 [J]. 中国医刊, 2008(1):14.doi: 10.3969/j.issn.1008-1070.2008.01.007.
    Sorensen H T, Mellemkjaer L, Olsen J H. Prognosis of cancers associated with venous thromboembolism [J]. New England Journal of Medicine, 2000, (25):1846.
    Geerts W H, Begvist D, Pineu G F. Prevention of venous thromboembolism:American College of Chest Physicians Evidence-based Clinical Practics Guidelines (8thEdition) [J]. Chest, 2008, (6 Suppl):381S.
    杨轶, 周箴, 艾星浩. 肺癌术后并发静脉血栓栓塞症的临床分析 [J]. 肿瘤, 2012(5):361.doi: 10.3781/j.issn.1000-7431.2012.05.009.
    孙景娟, 王旭, 王策. 肺癌合并静脉血栓栓塞的危险因素 [J]. 中国老年学杂志, 2012, (10):2026.doi: 10.3969/j.issn.1005-9202.2012.10.013.
    Horsted F, West J, Grainge M J. Risk of venous thromboembolism in patients with cancer:a systematic review and meta-analysis [J]. PLOS MEDICINE, 2012(7):e1001275.
计量
  • 文章访问数:  223
  • HTML全文浏览量:  27
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 发布日期:  2013-06-12

目录

    /

    返回文章
    返回
    x 关闭 永久关闭